Juan Jose Juarez-Vignon Whaley
Overview
Explore the profile of Juan Jose Juarez-Vignon Whaley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anorve Bailon D, Pico-Guzman J, Cifuentes S, Trejo R, Rodriguez Cid J, Juarez-Vignon Whaley J, et al.
Pharmacoecon Open
. 2024 Aug;
8(6):869-885.
PMID: 39107537
Introduction: Lung cancer continues to be the leading cause of death among cancer patients worldwide. This study aimed to estimate the clinical, economic, and social burdens of stage IV non-small...
2.
Juarez-Vignon Whaley J, Pophali P, Chornenkyy Y, Peters M
Case Rep Oncol
. 2024 Jul;
17(1):695-704.
PMID: 39015643
Introduction: Cancers of unknown primary are aggressive and rare malignancies with a complex diagnosis and management. Here we present a case in which imaging, pathology, and molecular biology did not...
3.
Rodriguez-Lara V, Soca-Chafre G, Avila-Costa M, Juarez-Vignon Whaley J, Rodriguez-Cid J, Ordonez-Librado J, et al.
Front Oncol
. 2023 Nov;
13:1210297.
PMID: 37941543
Currently, immunotherapy based on PD-1/PD-L1 pathway blockade has improved survival of non-small cell lung cancer (NSCLC) patients. However, differential responses have been observed by sex, where men appear to respond...
4.
Juarez-Vignon Whaley J, Afkhami M, Onyshchenko M, Massarelli E, Sampath S, Amini A, et al.
Curr Treat Options Oncol
. 2023 Jun;
24(9):1138-1166.
PMID: 37318724
Nasopharyngeal carcinoma (NPC) is distinct in its anatomic location and biology from other epithelial head and neck cancer (HNC). There are 3 WHO subtypes, which considers the presence of Epstein-Barr...
5.
Juarez-Vignon Whaley J, Afkhami M, Sampath S, Amini A, Bell D, Villaflor V
Curr Treat Options Oncol
. 2023 May;
24(7):845-866.
PMID: 37145382
Nasopharyngeal carcinoma (NPC) is a rare malignancy, endemic in China, that is commonly diagnosed in locally advanced scenarios. Its pathogenesis is strongly associated with Epstein-Barr virus (EBV), an infection for...
6.
Rodriguez-Cid J, Juarez-Vignon Whaley J, Sanchez-Dominguez G, Guzman-Casta J, Carrasco-CaraChards S, Guzman-Huesca J, et al.
J Cancer Res Clin Oncol
. 2022 Dec;
149(9):5479-5491.
PMID: 36463530
Purpose: Thoracic sarcomas are rare malignancies, with limited data for unresectable/advanced scenarios. Our goal is to provide insights of a three-drug chemotherapy regimen improving patient survival compared to standard regimens....
7.
Juarez-Vignon Whaley J, Carrera-Muinos A, Hernandez-Gutierrez K, Rodriguez-Cid J, Otero-Cerdeira M, Garcia-Montes V
Case Rep Oncol
. 2022 Feb;
14(3):1799-1805.
PMID: 35111012
Paraneoplastic neurological syndromes (PNS) are rare presentations of an underlying oncological disease and more unusual during an oncological disease. They most likely present in small-cell lung carcinomas and thymomas, but...
8.
Rodriguez-Barrera R, Flores-Romero A, Garcia E, Fernandez-Presas A, Incontri-Abraham D, Navarro-Torres L, et al.
CNS Neurosci Ther
. 2020 May;
26(6):650-658.
PMID: 32352656
Aims: Immunization with neural-derived peptides (INDP) has demonstrated to be a promising therapy to achieve a regenerative effect in the chronic phase of the spinal cord injury (SCI). Nevertheless, INDP-induced...
9.
Rodriguez-Barrera R, Flores-Romero A, Buzoianu-Anguiano V, Garcia E, Soria-Zavala K, Incontri-Abraham D, et al.
Front Neurol
. 2020 Apr;
11:189.
PMID: 32300328
Immunization with neural derived peptides (INDP), as well as scar removal (SR) and the use of matrices with bone marrow-mesenchymal stem cells (MSCs), have been studied separately and proven to...